Evidence map›Paper›PMID 25165633›Full record

ArticlePeerJ2014

Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation.

Alex M Clark, Barry A Bunin, Nadia K Litterman, Stephan C Schürer, Ubbo Visser

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alex M ClarkCollaborative Drug Discovery, Inc. , Burlingame, CA , USA.
Barry A BuninCollaborative Drug Discovery, Inc. , Burlingame, CA , USA.
Nadia K LittermanCollaborative Drug Discovery, Inc. , Burlingame, CA , USA.
Stephan C SchürerCenter for Computational Science, University of Miami , Miami, FL , USA.
Ubbo VisserCenter for Computational Science, University of Miami , Miami, FL , USA.
Collaborative Drug Discovery (United States) · USUniversity of Miami · US

Funding

Simplifying encoding of bioassays to accelerate translational drug discoveryR44TR000185 · NCATS · COLLABORATIVE DRUG DISCOVERY, INC. · PI BUNIN, BARRY A · 2015 to 2019
$3.0M
Bioassay Ontology and Software Tools to Integrate and Analyze Diverse Data SetsRC2HG005668 · NHGRI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEMMON, VANCE P, SCHURER, STEPHAN C · 2009 to 2012
$1.7M
LINCS Information FramEwork (LIFE) to Integrate and Analyze Diverse Data SetU01HL111561 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCHURER, STEPHAN C · 2011 to 2013
$1.6M
Simplifying encoding of bioassays to accelerate translational drug discoveryR43TR000185 · NCATS · COLLABORATIVE DRUG DISCOVERY, INC. · PI BUNIN, BARRY A · 2013 to 2013
$150k
NCATS NIH HHS R43 TR000185NCATS NIH HHS R44 TR000185NHGRI NIH HHS RC2 HG005668NHLBI NIH HHS U01 HL111561
6 · The paper itself

Abstract

Bioinformatics and computer aided drug design rely on the curation of a large number of protocols for biological assays that measure the ability of potential drugs to achieve a therapeutic effect. These assay protocols are generally published by scientists in the form of plain text, which needs to be more precisely annotated in order to be useful to software methods. We have developed a pragmatic approach to describing assays according to the semantic definitions of the BioAssay Ontology (BAO) project, using a hybrid of machine learning based on natural language processing, and a simplified user interface designed to help scientists curate their data with minimum effort. We have carried out this work based on the premise that pure machine learning is insufficiently accurate, and that expecting scientists to find the time to annotate their protocols manually is unrealistic. By combining these approaches, we have created an effective prototype for which annotation of bioassay text within the domain of the training set can be accomplished very quickly. Well-trained annotations require single-click user approval, while annotations from outside the training set domain can be identified using the search feature of a well-designed user interface, and subsequently used to improve the underlying models. By drastically reducing the time required for scientists to annotate their assays, we can realistically advocate for semantic annotation to become a standard part of the publication process. Once even a small proportion of the public body of bioassay data is marked up, bioinformatics researchers can begin to construct sophisticated and useful searching and analysis algorithms that will provide a diverse and powerful set of tools for drug discovery researchers.

Indexed as

BayesianBioassayMachine learningNatural language processingOntologySemantic curation

Identifiers

PMID25165633
PMCPMC4137659
OpenAlexW2163841005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.